Note 9 - NET LOSS PER SHARE - Anti-dilutive Securities (Details) - shares shares in Thousands	3 Months Ended	9 Months Ended
Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Anti-dilutive securities (in shares)	62	1,073	922	1,193
Share-based Payment Arrangement, Option [Member]
Anti-dilutive securities (in shares)		128	63	182
Restricted Stock Units (RSUs) [Member]
Anti-dilutive securities (in shares)	62	915	784	997
Employee Stock Purchase Plan [Member]
Anti-dilutive securities (in shares)		30	75	14

Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257

Name:	us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration